What is the global market size of Erectile Dysfunction Market?

Global erectile dysfunction market size was valued at US$ 3.64 billion in 2021, and it is expected to reach a value of US$ 5.94 billion by 2028, at a CAGR of 6.9% over the forecast period (2022 - 2028). Read More

Erectile Dysfunction Market Size, Share, Growth Analysis, By Product(Viagra, Cialis, Zydena, Levitra), By Region - Industry Forecast 2024-2031

Report ID: SQSG35I2033 | Region: Global | Published Date: July, 2036
Pages: 165 | Tables: 39 | Figures: 73

Erectile Dysfunction Market Insights

Erectile Dysfunction Market size was valued at USD 2.3 billion in 2022 and is poised to grow from USD 2.49 billion in 2023 to USD 4.73 billion by 2031, growing at a CAGR of 8.5% in the forecast period (2024-2031).

The inability to achieve or sustain a robust adequate penile erection during sexual activity is known as erectile dysfunction. It is the most prevalent condition affecting male sexual health. Because of stress, has an impact on the patient's physical and mental health. There are two basic causes of erectile dysfunction: psychological and physiological. Physiological causes include high blood pressure, high cholesterol, obesity, diabetes, smoking, and tobacco use.

The market for erectile dysfunction treatments is expanding as a result of an increase in the number of individuals with erectile dysfunction. Throughout the projection period, market participants are anticipated to become more knowledgeable about erectile dysfunction treatment. Nevertheless, one of the primary issues projected to limit the growth of the erectile dysfunction market is the high cost of penile implants.

US Erectile Dysfunction Market is poised to grow at a sustainable CAGR for the next forecast year.

Erectile Dysfunction Market Report Snapshots

License Type Top market research company in USA

File Type

$5,300

BUY NOW GET FREE SAMPLE

Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Key market participants in the erectile dysfunction (ED) drugs market are strengthening their market positions by implementing a variety of strategies, including mergers and acquisitions and research partnerships with other businesses, to introduce novel products and solidify their market positions globally. For instance, due to a production error, Sun Pharmaceutical Industries Ltd. announced the recall of their generic medicine Tadalafil in November 2021. A small gap in the availability of generic ED medications used to treat erectile dysfunction patients may result from this recall. 'Pfizer Inc.', 'Eli Lilly and Company', 'Bayer AG', 'VIVUS, Inc.', 'Dong-A ST Co. Ltd.', 'Meda Pharmaceuticals Inc.', 'S.K. Chemicals Co. Ltd.', 'Teva Pharmaceutical Industries Ltd.', 'Endo International plc', 'Futura Medical plc', 'Apricus Biosciences, Inc.', 'Medtronic plc', 'Coloplast Corp.', 'Boston Scientific Corporation', 'Zephyr Surgical Implants', 'Urologix, LLC', 'American Medical Systems, Inc.', 'Augusta Medical Systems, LLC', 'Pos-T-Vac Medical'

Diabetes, obesity, and cardiovascular disease are on the rise due to the rise in the adoption of an unhealthy lifestyle, which in turn causes issues like ED as people age. Young people's current lifestyles are particularly stressful in many emerging nations, which has led to an increase in fast food and ready-to-eat food consumption as well as drinking and smoking. These variables are compromising general health and fitness, which in turn raises the risk of ED. Additionally, the number of ED patients increases along with the senior population growth, which continues to be a major driver of the worldwide erectile dysfunction medications market during the projection period.

The medication sildenafil is used to treat erectile dysfunction. By boosting blood flow to the penis, it aids males in obtaining an erection. At least two-thirds of the men who took it said their erections got better. The drug sildenafil is used to treat pulmonary arterial hypertension and erectile dysfunction, among other conditions. It is marketed under the trade name Viagra among others. Its efficacy in treating female sexual dysfunction has not been shown. The most popular medication used as initial therapy for erectile dysfunction is sildenafil (Viagra). So, throughout the projection period, the segment is anticipated to grow due to the success of Viagra (sildenafil citrate) in the treatment of erectile dysfunction.

The erectile dysfunction industry is expected to be dominated by North America. The prevalence of erectile dysfunction, the well-developed healthcare system, and the accessibility of treatment tools are all factors in the supremacy.

Feedback From Our Clients

"We have purchased recently a report from SkyQuest Technology, and we are happy to inform you that this report was so useful and practical for our team. Skyquest Team was very active and our queries were followed up completely.It was amazing. "

- Mr. Ali Zali, Commercial Director, ICIIC Iran.

Erectile Dysfunction Market Size, Share, Growth Analysis, By Product(Viagra, Cialis, Zydena, Levitra), By Region - Industry Forecast 2024-2031

Erectile Dysfunction Market Insights

Erectile Dysfunction Market Report Snapshots

Want to customize this report?

FAQs

What is the global market size of Erectile Dysfunction Market?

Who are the key vendors in the Erectile Dysfunction Market?

What is the key driver of Erectile Dysfunction Market?

What is the key market trend for Erectile Dysfunction Market?

Which region accounted for the largest share in Erectile Dysfunction Market?

Request Free Customization

Related Reports

Feedback From Our Clients

$5,300